Could the development of novel vaccine candidates be better directed and predicted based on the genetic history of an individual and/or a genetically similar sub-population?
Until the late 1990s, vaccines were developed by an empirical method based on the “Isolate–Inactivate–Inject” paradigm. Traditional vaccinology relied on empirical screening of a few candidates at a time - a weakened or inactivated virus particle or a microbial party - such as a viral spike protein responsible for penetrating inside the cell or a bacterial toxin.
But vaccines are amenable to and should be personalized, based on results of high throughput “omics” technologies-based diagnostics.
... Read more ...